资讯

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...
The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...
Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The Food and Drug Administration will make it harder to approve COVID vaccines for healthy adults and children.